Status:
COMPLETED
Efficacy of Budesonide-Formoterol in Bronchiectasis
Lead Sponsor:
Hospital General de Requena
Collaborating Sponsors:
Esteve
Conditions:
Bronchiectasis
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Some studies have concluded that high-dose inhaled steroids (IS) are effective in the clinical control of patients with bronchiectasis, however the high doses needed provokes some adverse effects and ...
Eligibility Criteria
Inclusion
- 18-80 years old patients diagnosed of non-cystic fibrosis bronchiectasis
- More than 1 pulmonary lobe affected
- Chronic obstructive airflow obstruction
- Stable phase of the disease
Exclusion
- Asthma, COPD or current/past smnokers
- No consent
- Known intolerance to budesonide or formoterol
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2005
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00728715
Start Date
January 1 2004
End Date
January 1 2005
Last Update
August 6 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital General de Requena
Valencia, Valencia, Spain, 43260